Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
or

Mersana Therapeutics Inc (MRSN)

Mersana Therapeutics Inc (MRSN)
0.5232 x 15 0.5275 x 37
Post-market by (Cboe BZX)
0.5275 -0.0224 (-4.07%) 01/22/25 [NASDAQ]
0.5232 x 15 0.5275 x 37
Post-market 0.5275 unch (unch) 17:24 ET
Quote Overview for Wed, Jan 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.5189
Day High
0.5490
Open 0.5380
Previous Close 0.5499 0.5499
Volume 8,614,420 8,614,420
Avg Vol 8,040,091 8,040,091
Stochastic %K 2.61% 2.61%
Weighted Alpha -88.91 -88.91
5-Day Change -0.1065 (-16.80%) -0.1065 (-16.80%)
52-Week Range 0.5189 - 6.2801 0.5189 - 6.2801
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 67,931
  • Shares Outstanding, K 123,533
  • Annual Sales, $ 36,860 K
  • Annual Income, $ -171,670 K
  • EBIT $ -80 M
  • EBITDA $ -83 M
  • 60-Month Beta 1.43
  • Price/Sales 1.92
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.61
  • Most Recent Earnings $-0.09 on 11/13/24
  • Next Earnings Date 02/26/25
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 130.29% ( -21.99%)
  • Historical Volatility 189.71%
  • IV Percentile 54%
  • IV Rank 30.65%
  • IV High 388.14% on 01/14/25
  • IV Low 16.36% on 09/09/24
  • Put/Call Vol Ratio 0.63
  • Today's Volume 31
  • Volume Avg (30-Day) 712
  • Put/Call OI Ratio 1.51
  • Today's Open Interest 6,962
  • Open Int (30-Day) 24,631

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.16
  • Number of Estimates 5
  • High Estimate -0.11
  • Low Estimate -0.22
  • Prior Year -0.16
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5189 +1.66%
on 01/22/25
Period Open: 1.6000
1.6350 -67.74%
on 12/24/24
-1.0725 (-67.03%)
since 12/20/24
3-Month
0.5189 +1.66%
on 01/22/25
Period Open: 2.0500
2.8300 -81.36%
on 11/13/24
-1.5225 (-74.27%)
since 10/22/24
52-Week
0.5189 +1.66%
on 01/22/25
Period Open: 2.8200
6.2801 -91.60%
on 03/11/24
-2.2925 (-81.29%)
since 01/22/24

Most Recent Stories

More News
Mersana Therapeutics Announces Additional FDA Fast Track Designation Granted to Emiltatug Ledadotin (XMT-1660)

MRSN : 0.5275 (-4.07%)
Mersana Therapeutics Announces Positive Initial Clinical Data from Phase 1 Clinical Trial of Emiltatug Ledadotin (XMT-1660); Initiation of Expansion in Triple Negative Breast Cancer

MRSN : 0.5275 (-4.07%)
Mersana Therapeutics Provides Business Update and Announces Third Quarter 2024 Financial Results

MRSN : 0.5275 (-4.07%)
Mersana Therapeutics to Host Third Quarter 2024 Conference Call on November 13, 2024

MRSN : 0.5275 (-4.07%)
1 'Strong Buy' Russell 2000 Stock With 188% Upside Potential

As a part of the annual Russell Index reconstitution, this ‘Strong Buy’-rated penny stock is one of the new entrants to the Russell 2000 Index.

ADCT : 1.7000 (-3.41%)
$SPX : 6,086.37 (+0.61%)
MRSN : 0.5275 (-4.07%)
Elli Lilly Joins Big Pharma’s Multi-Billion-Dollar Oncology Race

Large pharmaceutical companies are increasingly investing in cancer treatment stocks, driven by the promise of medical breakthroughs and financial rewards. Eli Lilly became the latest Big Pharma giant...

DTC.CN : 0.8300 (+3.75%)
MGNX : 3.08 (+2.67%)
IOVA : 5.99 (+1.87%)
MRTX : 58.70 (-0.17%)
MRSN : 0.5275 (-4.07%)
DTCFF : 0.5600 (+34.94%)
LLY : 753.98 (+1.57%)
PFE : 26.01 (-2.36%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mersana Therapeutics, Inc. - MRSN

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Mersana Therapeutics, Inc. ("Mersana" or the "Company") (NASDAQ: MRSN). Such...

MRSN : 0.5275 (-4.07%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mersana Therapeutics, Inc. - MRSN

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Mersana Therapeutics, Inc. ("Mersana" or the "Company") (NASDAQ: MRSN). Such...

MRSN : 0.5275 (-4.07%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mersana Therapeutics, Inc. - MRSN

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Mersana Therapeutics, Inc. ("Mersana" or the "Company") (NASDAQ: MRSN). Such...

MRSN : 0.5275 (-4.07%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mersana Therapeutics, Inc. - MRSN

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Mersana Therapeutics, Inc. ("Mersana" or the "Company") (NASDAQ: MRSN). Such...

MRSN : 0.5275 (-4.07%)

Business Summary

Mersana Therapeutics, Inc. is a biotechnology company. It focused on discovering and developing a pipeline of antibody drug conjugates. The company's product candidates include XMT-1522 and XMT-1536 which are in clinical stage. Mersana Therapeutics, Inc. is based in CAMBRIDGE, United States.

See More

Key Turning Points

3rd Resistance Point 0.5758
2nd Resistance Point 0.5627
1st Resistance Point 0.5451
Last Price 0.5275
1st Support Level 0.5144
2nd Support Level 0.5013
3rd Support Level 0.4837

See More

52-Week High 6.2801
Fibonacci 61.8% 4.0793
Fibonacci 50% 3.3995
Fibonacci 38.2% 2.7197
Last Price 0.5275
52-Week Low 0.5189

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar